18 February 2024 While President Biden’s desire to reduce costs at the pharmacy counter is commendable, it is too blunt an ...

As Donald Trump celebrates a second term, LSIPR looks at how key IP areas could be affected ahead of his return to the Oval ...

A US biopharma firm must pay the damages to Sandoz over a long-running dispute over lung therapy | New Jersey district judge ...

A jury in Delaware unanimously dismissed all allegations of misappropriation against Inhibrx, a Sanofi-owned biotech firm | ...

UK High Court judge unconvinced by Pfizer that uniQure’s patent is invalid | Companies in dispute over patents covering ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

Startup CFO’s betrayal is a lesson in preparing for the worst ...

Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.

A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 ...

New hire specialises in guiding life sciences and health tech clients through compliance issues | Work includes US regulations, including those enforced by the FDA, Drug Enforcement Administration and ...

The government’s autumn budget sends a positive signal but a more comprehensive approach is required to unlock the UK’s potential, says Graeme Moore of Mewburn Ellis.